- 专利标题： DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
-
申请号： EP23209136.3申请日： 2016-04-13
-
公开(公告)号： EP4331578A2公开(公告)日： 2024-03-06
- 发明人: SAHIN, Ugur , TÜRECI, Özlem , WALTER, Korden , KREUZBERG, Maria , MITNACHT-KRAUS, Rita , LE GALL, Fabrice , JACOBS, Stefan
- 申请人： Astellas Pharma Inc. , TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
- 申请人地址： JP Chuo-ku Tokyo 103-8411 5-1, Nihonbashi-Honcho 2-Chome; DE 55131 Mainz Freiligrathstrasse 12
- 代理机构： Müller, Christian Stefan Gerd
- 优先权： WOPCT/EP2015/058206 20150415
- 主分类号： A61K31/40
- IPC分类号： A61K31/40
摘要：
The present invention provides anti-CLDN18.2 antibody-drug conjugates which are effective for treating and/or preventing cancer diseases associated with cells expressing CLDN18.2, including gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
公开/授权文献
- EP4331578A3 DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2 公开/授权日：2024-06-05
信息查询
